Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by King, A. A.
Right arrow Articles by DeBaun, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, A. A.
Right arrow Articles by DeBaun, M. R.
Related Collections
Right arrow Childhood stroke
Right arrow All Clinical trials
Right arrow Memory
Right arrow All Rehabilitation
NEUROLOGY 2007;68:2008-2011
© 2007 American Academy of Neurology

A pilot randomized education rehabilitation trial is feasible in sickle cell and strokes

A. A. King, MD, MPH, D. A. White, PhD, R. C. McKinstry, MD, PhD, M. Noetzel, MD and M. R. DeBaun, MD, MPH

From the Washington University School of Medicine, St. Louis, MO.

Address correspondence and reprint requests to Dr King, Washington University School of Medicine, 660 S. Euclid, Box 8116, St. Louis, MO 63110 king_a{at}kids.wustl.edu

A randomized trial was completed to assess the feasibility of a 2-year education rehabilitation program for students with sickle cell disease and memory deficits. Eleven students were assigned to tutoring with or without memory training for 2 years. Eighty-two percent completed the program. Evidence of improvement in memory and academic achievement existed. Educational rehabilitation is a feasible strategy, but further investigation is needed to assess the benefit in a multi center trial.

Supported by the American Heart Association, the Greater St. Louis Health Association, and the Doris Duke Charitable Foundation.

Disclosure: The authors report no conflicts of interest.

Received August 10, 2006. Accepted in final form February 5, 2007.




This article has been cited by other articles:


Home page
 Arch. Dis. Child.Home page
J Pappachan and F J Kirkham
Cerebrovascular disease and stroke
Arch. Dis. Child., October 1, 2008; 93(10): 890 - 898.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by AAN Enterprises, Inc.